ϳԹ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ϳԹ News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Apr 12 2021

Full Issue

Reactions To Johnson & Johnson Covid Vaccine Cause Rollout Problems

Eight people in Georgia suffered adverse reactions to taking the J&J vaccine, causing the state to pause vaccinations — at least the third state to encounter this issue. The CDC is evaluating the situation.

Johnson & Johnson's coronavirus vaccine is facing a double dose of problems. Georgia is the third state to temporarily shut down a vaccine site after eight people suffered adverse reactions to the shot. Earlier this week, 18 people in North Carolina reported side effects, while 11 people in Colorado reacted to the shot with symptoms ranging from dizziness, nausea and fainting. "This is a really potent vaccine, and what we're seeing is some of that potency relating at a very rare side effect that we just have to be aware of," said Dr. David Agus, a CBS News medical contributor.  (Battiste, 4/10)

State officials are halting COVID vaccinations at a Cumming site after eight people had adverse reactions to getting a Johnson & Johnson shot there Wednesday. The CDC is evaluating the situation in the Atlanta suburb and in three other states – Iowa, Colorado and Michigan. (Miller, 4/9)

Johnson & Johnson's coronavirus vaccine rollout hit several unfortunate snags this week — some far worse than others.  ... The timing of these developments was unfortunate, experts said, but there's no reason to doubt the shot's safety yet. "You don't want to be fueling unnecessary worries about the safety of vaccines when you're still seeing an enormous outbreak and death rates all over the world from COVID," Art Caplan, a bioethicist at New York University, told Insider. He added that the side effects observed at the US vaccination sites were "absolutely trivial." (Bendix, 4/10)

And there are more reports of people contracting covid after being fully vaccinated —

Laura Eugene's husband is in the hospital fighting for his life. She says they got the Johnson & Johnson vaccine back on March 6. Eugene says on April 1, her husband started to feel sick. "He started to feel like he had a sore throat stuffy, his coughing and then he started to run a fever, started to feel fatigue. He just gets it every day -- just kept on getting a symptom," she said. Her husband tested positive for COVID on April 1, she says. Now he is in critical condition and is being treated for pneumonia as well. (Yang, 4/11)

She’s shot out of luck. A Brooklyn woman who managed to avoid catching COVID-19 throughout 2020 went down with the bug this month — three weeks after being vaccinated. Ashley Allen, 31, spoke to The Post by phone while quarantined in her Williamsburg apartment and in between calls from city contact tracers. The contact tracers “started asking me questions about what I was doing three weeks ago,” Allen said. “And I said I was getting vaccinated.” Allen was thrilled when she was able to book an appointment for the one-dose Johnson & Johnson vaccine at the Javits Center on March 10. (Levine, 4/10)

In other news —

Emergent BioSolutions, the troubled manufacturer at the heart of Johnson & Johnson’s coronavirus vaccine production problems, gave its chief executive officer a 51 percent increase in total compensation in 2020, to $5.6 million, according to a public filing Friday. The annual proxy disclosure by the publicly traded company said CEO Robert Kramer received $893,000 in salary, a $1.2 million bonus, $2.1 million in stock awards, and $1.4 million in stock options. (Rowland, 4/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ϳԹ
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF